Macitentan is a dual endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension to help reduce pulmonary vascular resistance and improve exercise capacity. This category offers… Read more











![Chemical structure of N-[5-(4-Bromophenyl)-6-(2-(2-hydroxyethoxy)ethoxy)-4-pyrimidinyl]-N'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2211969-79-6-N-5-4-Bromophenyl-6-2-2-hydroxyethoxyethoxy-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Bromophenyl)-6-[2-chloroethoxy]-4-pyrimidinyl]-N'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2365406-87-5-N-5-4-Bromophenyl-6-2-chloroethoxy-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Bromophenyl)-6-[2-hydroxyethoxy]-4-pyrimidinyl]-N'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1393813-43-8-N-5-4-Bromophenyl-6-2-hydroxyethoxy-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N'-ethylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F441797-83-7-N-5-4-Bromophenyl-6-chloro-4-pyrimidinyl-N-ethylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1393813-42-7-N-5-4-Bromophenyl-6-chloro-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Bromophenyl)-6-hydroxy-4-pyrimidinyl]-N'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2365406-85-3-N-5-4-Bromophenyl-6-hydroxy-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Bromophenyl)-6-vinyloxy-4-pyrimidinyl]-N'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-5-4-Bromophenyl-6-vinyloxy-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Bromophenyl)-[6-methoxy] 4-pyrimidinyl]-n'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-5-4-Bromophenyl-6-methoxy-4-pyrimidinyl-n-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[5-(4-Hydroxyphenyl)-6-hydroxy-4-pyrimidinyl]-N'-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-5-4-Hydroxyphenyl-6-hydroxy-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[6-[2-[(5-Bromo-2-pyrimidinyl)oxy]ethoxy]-5-phenyl-4-pyrimidinyl]-N′-propylsulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2300968-87-8-N-6-2-5-Bromo-2-pyrimidinyloxyethoxy-5-phenyl-4-pyrimidinyl-N-propylsulfamide.png&w=3840&q=75)
![Chemical structure of N-[6-[2-[(5-Chloro -2-pyrimidinyl)oxy]ethoxy]-5-(4-chlorophenyl)-4-pyrimidinyl]-N’-propyl-sulfamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-6-2-5-Chloro-2-pyrimidinyloxyethoxy-5-4-chlorophenyl-4-pyrimidinyl-N-propyl-sulfamide.png&w=3840&q=75)























Macitentan is a dual endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension to help reduce pulmonary vascular resistance and improve exercise capacity. This category offers a comprehensive range of Macitentan reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories conducting routine quality control, analytical method development, and impurity profiling to ensure drug product safety and efficacy. By utilizing high-quality reference standards, analysts can accurately identify and quantify degradation products formed through pathways such as oxidation or hydrolysis. Furthermore, the inclusion of stable isotope labelled compounds supports precise mass spectrometry-based assays and sensitive testing protocols. These analytical tools facilitate consistent compliance with regulatory guidelines and rigorous verification throughout the entire drug development lifecycle, from initial characterization to long-term stability studies.